Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study

Kim A. Papp, R. G. Langley, B. Sigurgeirsson, M. Abe, D. R. Baker, P. Konno, S. Haemmerle, H. J. Thurston, C. Papavassilis, H. B. Richards

科研成果: 期刊稿件 › 文章 › 同行评审

327 引用 （Scopus）

指纹

探究 'Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Immunology and Microbiology

Medicine and Dentistry